...

As a clinical psychologist with a specialty in chronic pain management, I am often referred patients with both chronic pain and psychiatric issues. Many of these patients see a psychiatrist and a therapist, and are taking with both psychotropic and pain medications. The referral is often made because there is...

Ever wish you could improve treatment compliance among your patients who receive buprenorphine? Ever wish you could offer them the benefit of sublingual buprenorphine while avoiding the risk of diversion and abuse? Well, now you can—maybe.

Many chronic pain patients are dealing with psychiatric problems. Pain patients have tremendously high rates of major depressive disorder which is undertreated and underdiagnosed. It's easy to assume that the depression is a reaction to living with chronic pain, but in fact it’s often the other way around. Dr. Michael Robert Clark describes evaluations and treatment methods clinicians can use to address pain management with their patients.

Effective pharmacological treatments for cannabis dependence have eluded the field of addiction psychiatry. It’s not, however, due to a lack of trying. Theoretical connections between cannabinoids and the serotonin system have spurred a number of studies looking at the usefulness of SSRIs and buspirone.

While there is some overlap with major depression, complicated grief has core symptoms of yearning and sorrow and great difficulty accepting the reality of death. It’s one of the more controversial proposed DSM disorders, with critics seeing it as medicalizing a normal human experience.

...

We’ve been hearing for some time now about the FDA’s plans to revise the long-standing categories A, B, C, D, and X designations for risk of using medications in pregnancy. The new rule (referred to as PLLR for Pregnancy and Lactation Labeling Rule) was proposed in 2008, finalized in 2014,...

...

We’ve been hearing for some time now about the FDA’s plans to revise the long-standing categories A, B, C, D, and X designations for risk of using medications in pregnancy. The new rule (referred to as PLLR for Pregnancy and Lactation Labeling Rule) was proposed in 2008, finalized in 2014, and implementation began during the summer of 2015.